Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jul 2011. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
65302301000001110 | Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
101270401000001116 | Bydureon 2mg powder and solvent for prolonged-release suspension for injection vials (AstraZeneca UK Ltd) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) 4 vial | Has AMP | True | Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets